VITAL

Product Launch

Answers in
minutes.

Lab-quality diagnostics at the point of care.

18 min

Turnaround

18 min

Headline metric

Press & media

Prepared for

01 / 20

The problem

A blood test still takes days — we return the same panel in under twenty minutes.

diagnostics teams feel it every week: the status quo scales cost, not outcomes. There is no clean upgrade path — only rip-and-replace.

02 / 20

Market

01

18 min

Turnaround

02

98%

Concordance vs lab

03

22

Biomarkers

Bottom-up, the reachable market clears a nine-figure ceiling before expansion.

03 / 20

[ FULL-BLEED · diagnostics hero image ]

No waiting
room.

04 / 20

How it works

STEP 01

Connect

Map the whole diagnostics surface in under an hour. No migration.

→

STEP 02

VITAL core

Golden paths become policy, enforced at runtime.

→

STEP 03

Deliver

Teams self-serve safely with audit and rollback for free.

05 / 20

The product

One surface your whole press & media lives in.

01

Live graph

Every dependency, owner, and cost in real time.

02

Policy-as-code

Guardrails that block bad changes automatically.

03

Attribution

Every dollar tied to a team and a decision.

[ product UI screenshot ]

06 / 20

Traction

Turnaround, last 8 quarters

18 min

+200% YoY

25

50

75

100

168

199

241

312

382

466

601

771

Q3·24Q4·24Q1·25Q2·25Q3·25Q4·25Q1·26Q2·26

07 / 20

Why now

Three forces converging

01

Demand

diagnostics budgets are shifting from headcount to platform.

02

Technology

The primitives finally exist to do this at the edge.

03

Distribution

A bottom-up motion the incumbents can’t run.

08 / 20

Adoption

Active accounts

M1M3M6M9M12M15M18

actualguide

09 / 20

Landscape

VITAL

Legacy A

Point tool B

DIY

Breadth → ↑ Depth

10 / 20

Two

Part Two

The science.

Assay validation and comparison data.

11 / 20

Detail

Unit economics

This yearLast yearYoY

Revenue771466+36%

Gross margin78%71%+7 pts

Net retention134%119%+15 pts

Payback11 mo17 mo−6 mo

12 / 20

Where it goes

Use of funds

01

Engineering & product49%

02

Go-to-market40%

03

Operations & reserve11%

13 / 20

Cohorts

Retention by cohort

M0

M3

M6

M9

M12

Jan

100

88

79

72

68

Apr

100

90

82

76

—

Jul

100

91

85

—

Oct

100

93

—

LOWHIGH

14 / 20

Roadmap

The next 18 months

Now → Q2

Land

Own the diagnostics beachhead with a self-serve motion.

Q3 → Q4

Expand

Enterprise controls, SSO, and the partner program.

2027

Platform

Open the API and the marketplace.

15 / 20

“

In their words

“This collapses a three-day loop into a single visit.”

Dr. K. Osei

Medical Director

16 / 20

Revenue mix

Where the money comes from

0100%

49%

40%

Platform 49%

Services 40%

Marketplace 11%

17 / 20

Team

Built by operators

[ photo ]

Dr. K. Osei

Co-founder & CEO

[ photo ]

A. Rivera

Co-founder & CTO

[ photo ]

M. Osei

VP Product

[ photo ]

L. Chen

VP Revenue

18 / 20

In one number

18 min

from sample to a 22-biomarker panel, 98% concordant with central labs.

19 / 20

VITAL